Serving Northern California from Fresno to Monterey to the Oregon border
Robert Fisher M.D., Ph.D.
Professional Advisory Board Member
Robert Fisher, M.D., Ph.D.is the Director of the Stanford Epilepsy Center and the Maslah Saul M.D. Professor in the Stanford Department of Neurology. Dr. Fisher received his Ph.D. in Neuroscience at Stanford University and his M.D. from Stanford's School of Medicine, where he also completed his residency. He went on to complete his fellowship at John Hopkins University.
Dr. Fisher's research focuses on new devices to treat epilepsy. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials, drug delivery directly to a seizure focus in the brain, and diagnosis and treatment of non-epileptic seizures, the post-ictal state (the condition in the aftermath of a seizure).
Dr. Fisher has received research awards from the Klingenstein Foundation, the Epilepsy Foundation, CURE, and the National Institute of Health. He has been named
in Best Doctors in America every year between 1996-2015. Dr. Fisher received the Ambassador Award from the International League Against Epilepsy (ILAE), the 2005 American Epilepsy Society (AES) Service Award and the 2006 Annual Clinical Research Award. Dr. Fisher is Past President of AES and has served on the Board of the ILAE and as Editor-in-Chief of the Journal, Epilepsia. He is past Editor-in Chief of the website epilepsy.com and is an international leader and teacher about epilepsy treatment and research.
Playing the Soprano Sax at Gala
Did You Know? Dr. Fisher has published 211 peer-reviewed articles and five books.
Originally from Brooklyn, NY, Dr. Fisher enjoys reading science fiction novels and playing the soprano saxophone (he performed at the 2014 Gala!). He and his wife Donna enjoy boating, taking walks together in the woods, and watching old movies!
There are more than twice as many people with epilepsy in the US as the number of people with cerebral palsy (500,000), muscular dystrophy (250,000), multiple sclerosis (350,000), and cystic fibrosis (30,000) combined.